Rollins School of Public Health | Faculty Profile
Emory Rollins School of Public Health

Kevin  Ward

Research Assistant Professor

Faculty, Epidemiology

Kevin has worked in cancer surveillance, registration and control for over 24 years.  He joined the Georgia Center for Cancer Statistics at Emory University in 1997 as a data analyst and became the Director of this same organization in 2009.  He currently serves as the PI for the National Cancer Institute’s Georgia Surveillance, Epidemiology and End Results (SEER) Registry and is a Research Assistant Professor in the Department of Epidemiology at the Rollins School of Public Health.   

Kevin has extensive experience with surveillance systems, registry developement, cancer prevention and control activities, population science, registry operations, data security, electronic capture of cancer case data, linkage of data to external data sources, and uses of the registry for research purposes.  He collaborates with students and researchers across the nation to analyze existing registry datasets (like SEER-Medicare or SEER-MHOS) and to utilize the population-based Georgia Cancer Registry as a linkage source or sampling frame for countless research studies.  Data from his Center furthers our understanding of cancer in Georgia and is used to develop strategies and policies for cancer prevention and control.   

Contact Information

1518 Clifton Road NE, GCR 764

Atlanta , GA 30033

Phone: (404) 727-8455

Fax: (404)727-7261



Update Profile Here

Areas of Interest

  • Bioinformatics
  • Cancer Prevention
  • Disease Surveillance
  • Health Disparities
  • Statistical Modeling
  • Surveillance

Affiliations & Activities

Current/Recent Positions

2019-present   Executive Board Member, North American Association of Central Cancer Registries (NAACCR)

2014-2019       Advisory Committee, International Agency for Research on Cancer (IARC) Izmir Hub

2014-2018       Executive Board, North American Representative, International Association of Cancer Registries

2009-present   Chair, Data Evaluation and Certification Committee, NAACCR



  • , , Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients., J Clin Oncol, ,
  • , , Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer, Cancer, 124, 3668-3676
  • , , Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer, JAMA Surg, 153, 909-916
  • , , Downstream Breast Imaging Following Screening Mammography in Medicare Patients with Advanced Cancer: A Population-Based Study, J Gen Intern Med, 33, 284-290
  • , , Excess Cost and Predictive Factors of Esophagectomy Complications in the SEER-Medicare Database, Ann Thorac Surg, 106, 1484-1491
  • , , Frequency and distribution of primary site among gender minority cancer patients: An analysis of U.S. national surveillance data, Cancer Epidemiol, EPub ahead of print,
  • , , Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer, J Clin Oncol, 36, 1218-1224
  • , , Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and ?zmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program, Turk J Gastroenterol., 29, 36-44
  • , , Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer, Cancer, 124, 2714-2723
  • , , Preferences for Physician Roles in Follow-up Care During Survivorship: Do Patients, Primary Care Providers, and Oncologists Agree?, J Gen Intern Med, Epub ahead of print,
  • , , Pregnancy after cancer: Does timing of conception affect infant health?, Cancer, 124, 4401-4407
  • , , Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer, J Natl Cancer Inst, 110, 493-500
  • , , The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program, BMC Cancer, 18, 481-486
  • , , Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer, JAMA Oncol, 4, 1066-1072